Average Co-Inventor Count = 2.38
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Neupharma, Inc. (29 from 41 patents)
2. Plexxikon Inc. (5 from 106 patents)
3. Elan Pharmaceuticals, Inc. (2 from 202 patents)
4. Suzhou Neupharma Co., Ltd. (8 patents)
36 patents:
1. 12403145 - Substituted quinazolines for inhibiting kinase activity
2. 12018002 - Certain chemical entities, compositions, and methods
3. 11865120 - Substituted quinazolines for inhibiting kinase activity
4. 11304957 - Substituted quinazolines for inhibiting kinase activity
5. 11208388 - Certain chemical entities, compositions, and methods
6. 10947201 - Certain chemical entities, compositions, and methods
7. 10759766 - Certain chemical entities, compositions, and methods
8. 10653701 - Substituted quinazolines for inhibiting kinase activity
9. 10590106 - Certain chemical entities, compositions, and methods
10. 10561652 - Benzenesulfonamide derivatives of quinoxaline, pharmaceutical compositions thereof, and their use in methods for treating cancer
11. 10544106 - Certain chemical entities, compositions, and methods
12. 10457641 - Certain chemical entities, compositions, and methods
13. 10426760 - Compounds and methods for kinase modulation, and indications therefor
14. 10172868 - Substituted quinazolines for inhibiting kinase activity
15. 10137125 - Benzenesulfonamide derivatives of quinoxaline, pharmaceutical compositions thereof, and their use in methods for treating cancer